These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 26805406)
1. Inflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-β1. Trivanović D; Jauković A; Krstić J; Nikolić S; Okić Djordjević I; Kukolj T; Obradović H; Mojsilović S; Ilić V; Santibanez JF; Bugarski D IUBMB Life; 2016 Mar; 68(3):190-200. PubMed ID: 26805406 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I. Liu X Cell Motil Cytoskeleton; 2008 Dec; 65(12):935-44. PubMed ID: 18792103 [TBL] [Abstract][Full Text] [Related]
3. Antrodin C inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via suppression of Smad2/3 and β-catenin signaling pathways. Kumar KJ; Vani MG; Chueh PJ; Mau JL; Wang SY PLoS One; 2015; 10(2):e0117111. PubMed ID: 25658913 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723 [TBL] [Abstract][Full Text] [Related]
6. TGF-β1-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells. Singh R; Shankar BS; Sainis KB Cell Signal; 2014 Jul; 26(7):1604-15. PubMed ID: 24705025 [TBL] [Abstract][Full Text] [Related]
7. Spred2 inhibits TGF-beta1-induced urokinase type plasminogen activator expression, cell motility and epithelial mesenchymal transition. Villar V; Kocić J; Santibanez JF Int J Cancer; 2010 Jul; 127(1):77-85. PubMed ID: 19908229 [TBL] [Abstract][Full Text] [Related]
8. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells. Kim S; Lee J; Jeon M; Nam SJ; Lee JE Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1. Yamauchi Y; Kohyama T; Takizawa H; Kamitani S; Desaki M; Takami K; Kawasaki S; Kato J; Nagase T Exp Lung Res; 2010 Feb; 36(1):12-24. PubMed ID: 20128678 [TBL] [Abstract][Full Text] [Related]
10. Salinomycin suppresses TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells. Zhang C; Lu Y; Li Q; Mao J; Hou Z; Yu X; Fan S; Li J; Gao T; Yan B; Wang B; Song B; Li L Chem Biol Interact; 2016 Mar; 248():74-81. PubMed ID: 26896736 [TBL] [Abstract][Full Text] [Related]
11. SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes. Kocic J; Bugarski D; Santibanez JF Eur J Cancer; 2012 Jul; 48(10):1550-7. PubMed ID: 21798735 [TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells. Gao J; Yan Q; Wang J; Liu S; Yang X J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054 [TBL] [Abstract][Full Text] [Related]
13. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer. Zhang JT; Jiang XH; Xie C; Cheng H; Da Dong J; Wang Y; Fok KL; Zhang XH; Sun TT; Tsang LL; Chen H; Sun XJ; Chung YW; Cai ZM; Jiang WG; Chan HC Biochim Biophys Acta; 2013 Dec; 1833(12):2961-2969. PubMed ID: 23916755 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of invasion and epithelial-mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression. Lv M; Li Y; Ji MH; Zhuang M; Tang JH Mol Med Rep; 2014 Jul; 10(1):341-6. PubMed ID: 24756435 [TBL] [Abstract][Full Text] [Related]
16. Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells. Chen ZY; Wang PW; Shieh DB; Chiu KY; Liou YM J Biomed Sci; 2015 Oct; 22():90. PubMed ID: 26482896 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced secretion of TGF-β1 in mesenchymal stem cell promotes breast cancer cell progression. Hung SP; Yang MH; Tseng KF; Lee OK Cell Transplant; 2013; 22(10):1869-82. PubMed ID: 23067574 [TBL] [Abstract][Full Text] [Related]
18. SKIP is required for TGF-β1-induced epithelial mesenchymal transition and migration in transformed keratinocytes. Villar V; Kocic J; Bugarski D; Jovcic G; Santibanez JF FEBS Lett; 2010 Nov; 584(22):4586-92. PubMed ID: 20965173 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells promote pancreatic adenocarcinoma cells invasion by transforming growth factor-β1 induced epithelial-mesenchymal transition. Zhou HS; Su XF; Fu XL; Wu GZ; Luo KL; Fang Z; Yu F; Liu H; Hu HJ; Chen LS; Cai B; Tian ZQ Oncotarget; 2016 Jul; 7(27):41294-41305. PubMed ID: 27191496 [TBL] [Abstract][Full Text] [Related]
20. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer. Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]